Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Orbis Diagnostics works in Biotechnology Research, out of Auckland, AUK. Privately held, at orbisdiagnostics.com. It holds one address on record, all in New Zealand. It employs 16 people, on the record. The latest round on record is Grant at US$6.7K. The record links eight similar brands, most of them in Medical Device.
Orbis Diagnostics is a next-generation point of care diagnostics company that is transforming personal healthcare. Powered by microfluidic and photonic innovations, Orbis’ automated desktop system has miniaturised medical labs to deliver real-time, actionable test results from a finger-prick of blood. Orbis is developing a comprehensive portfolio of diagnostic solutions that will improve health outcomes by making routine blood testing more convenient and accessible.
| Countries | 1 |
|---|---|
| Primary country | NZ |
All codes: NZ
| Rounds | 6 |
|---|---|
| Axis | 2024 to 2027 |
| Grant · 1 Aug 2024 | US$ 6.7K |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
16 counted staff profiles at January 2026, inside the self-reported 11–50 band.
One address on record, New Zealand only. Primary: 14 West Street, Auckland, AUK 1010.
Six rounds. Latest 1 August 2024: grant, US$6,700, investor Callaghan Innovation.
10 profiles list Orbis Diagnostics as a peer — 82nd percentile in Biotechnology Research. It lists ten peers of its own. PowerON - Smart Elastic and Tectonus Seismic Technology list it back.